title: Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse.
abstract: Signal transducer and activator of transcription (Stat)5a is a critical regulator of mammary gland development. Previous studies have focused on Stat5a's role in the late pregnant and lactating gland, and although active Stat5a is detectable in mammary epithelial cells in virgin mice, little is known about its role during early mammary gland development. In this report, we compare mammary gland morphology in pubertal and adult nulliparous wild-type and Stat5a-/- mice. The Stat5a-null mammary glands exhibited defects in secondary and side branching, providing evidence that Stat5a regulates these processes. In addition, Stat5a-/- mammary glands displayed an attenuated proliferative response to pregnancy levels of estrogen plus progesterone (E+P), suggesting that it plays an important role in early pregnancy. Finally, we examined one potential mediator of Stat5a's effects, receptor activator of nuclear factor-kappaB ligand (RANKL). Stat5a-/- mammary glands were defective in inducing RANKL in response to E+P treatment. In addition, regulation of several reported RANKL targets, including inhibitor of DNA binding 2 (Id2), cyclin D1, and the cyclin-dependent kinase inhibitor p21(Waf1/Cip1), was altered in Stat5a-/- mammary cells, suggesting that one or more of these proteins mediate the effects of Stat5a in E+P-treated mammary epithelial cells.
authors.affiliation: Department of Microbiology and Molecular Genetics, 2209 Biomedical and Physical Sciences Building, Michigan State University, East Lansing, Michigan 48824, USA.
authors.forename: Sarah J
authors.initials: SJ
authors.lastname: Santos
authors.forename: Sandra Z
authors.initials: SZ
authors.lastname: Haslam
authors.forename: Susan E
authors.initials: SE
authors.lastname: Conrad
mesh_terms: D000818:Animals; D049109:Cell Proliferation / Q000187:drug effects; D019938:Cyclin D1 / Q000378:metabolism; D004967:Estrogens / Q000494:pharmacology; D015151:Immunoblotting; D007150:Immunohistochemistry; D008321:Mammary Glands, Animal / Q000166:cytology* / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D011374:Progesterone / Q000494:pharmacology; D011388:Prolactin / Q000494:pharmacology; D053245:RANK Ligand / Q000378:metabolism; D050799:STAT5 Transcription Factor / Q000235:genetics / Q000502:physiology*; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology*
chemical_list: D004967:Estrogens; D053245:RANK Ligand; D050799:STAT5 Transcription Factor; C494093:Stat5a protein, mouse; C505689:Tnfsf11 protein, mouse; D019938:Cyclin D1; D011374:Progesterone; D011388:Prolactin
references.citation: Cell. 2000 Sep 29;103(1):41-50
references.pmid: 11051546
references.citation: J Mammary Gland Biol Neoplasia. 2006 Oct;11(3-4):283-97
references.pmid: 17089203
references.citation: Mol Cell Biol. 2006 Feb;26(3):1002-13
references.pmid: 16428453
references.citation: Mol Endocrinol. 2002 Dec;16(12):2892-901
references.pmid: 12456807
references.citation: Endocrinology. 2008 Jan;149(1):329-38
references.pmid: 17884938
references.citation: J Biol Chem. 2003 Nov 14;278(46):46171-8
references.pmid: 12952963
references.citation: EMBO J. 2000 Nov 1;19(21):5772-81
references.pmid: 11060028
references.citation: Mol Cell Biol. 1997 Oct;17(10):5888-96
references.pmid: 9315646
references.citation: Endocrinology. 2007 May;148(5):2290-300
references.pmid: 17317767
references.citation: Cell. 1998 May 29;93(5):841-50
references.pmid: 9630227
references.citation: Dev Biol. 2009 Apr 1;328(1):127-39
references.pmid: 19298785
references.citation: Mol Cell Biol. 2004 Sep;24(18):8037-47
references.pmid: 15340066
references.citation: Cell Growth Differ. 1998 Sep;9(9):795-803
references.pmid: 9751123
references.citation: Science. 1997 Sep 12;277(5332):1630-5
references.pmid: 9287210
references.citation: Mol Endocrinol. 2002 May;16(5):1108-24
references.pmid: 11981045
references.citation: Dev Biol. 1999 Aug 1;212(1):1-11
references.pmid: 10419681
references.citation: Genes Dev. 1997 Jan 15;11(2):179-86
references.pmid: 9009201
references.citation: J Cell Biol. 2001 Nov 12;155(4):531-42
references.pmid: 11706048
references.citation: Cancer Cell. 2003 Jun;3(6):525-30
references.pmid: 12842081
references.citation: Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8831-5
references.pmid: 7568026
references.citation: Cell. 1996 Feb 9;84(3):331-4
references.pmid: 8608586
references.citation: Endocrinology. 2008 May;149(5):2098-107
references.pmid: 18218689
references.citation: Endocrinology. 2009 Mar;150(3):1485-94
references.pmid: 18988671
references.citation: J Mammary Gland Biol Neoplasia. 2006 Oct;11(3-4):239-48
references.pmid: 17111223
references.citation: Mol Cell Biol. 2007 Feb;27(4):1442-54
references.pmid: 17145767
references.citation: Cell. 2001 Dec 14;107(6):763-75
references.pmid: 11747812
references.citation: Genes Dev. 1994 Jun 1;8(11):1270-84
references.pmid: 7926730
references.citation: Trends Cell Biol. 2003 Aug;13(8):410-8
references.pmid: 12888293
references.citation: Int J Cancer. 2004 Nov 20;112(4):607-19
references.pmid: 15382041